AnaptysBio, Inc. (ANAB)
63.15
+0.96
(+1.54%)
USD |
NASDAQ |
May 15, 16:00
63.22
+0.07
(+0.11%)
After-Hours: 20:00
AnaptysBio Total Assets (Quarterly) : 329.68M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 433.52M |
| TG Therapeutics, Inc. | 1.529B |
| ADMA Biologics, Inc. | 665.18M |
| Mirum Pharmaceuticals, Inc. | 890.92M |
| Rocket Pharmaceuticals, Inc. | 285.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 316.94M |
| Shareholders Equity (Quarterly) | 12.75M |
| Debt to Equity Ratio | 21.76 |
| Current Ratio | 7.580 |
| Net Debt Paydown Yield | 1.72% |